Drug intelligence / Profile preview

measles vaccine virus

Development stage
Preclinical
Lead developer
University Hospital Tuebingen
Modality
Oncolytic Viruses → Oncolytic Therapeutics, Vaccines & Immunotherapeutics
Administration
Systemic, Intratumoral, Intraperitoneal
01

Overview

Measles vaccine virus (MeV) is a negative-stranded RNA virus belonging to the paramyxovirus group, known for its excellent safety record as a vaccine for over 50 years. It is being investigated as an oncolytic virus (OV) for cancer therapy, particularly for pancreatic cancer. As an oncolytic virus, MeV selectively infects, replicates within, and lyses tumor cells, especially those with impaired anti-viral interferon pathways, leading to subsequent waves of oncolytic tumor cell death and induction of a profound systemic anti-tumoral immune response. Specific recombinant versions, such as MeV-SCD (suicide gene-armed vector) and MeV-GFP (carrying a green fluorescent marker protein), have been generated from original vaccine batches for research purposes.

Beyond the preview

Go deeper on measles vaccine virus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on measles vaccine virus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call